Plant ID: NPO19264
Plant Latin Name: Macleaya cordata
Taxonomy Genus: Macleaya
Taxonomy Family: Papaveraceae
NCBI TaxonomyDB:
56857
Plant-of-the-World-Online:
673258-1
Carminative; Depurative; Diuretic; Stings
Ukraine; United States; China; South Africa
TRPA1; | |
MTOR; ALOX15; | |
PTGS1; | |
TP53; | |
SMN1;SMN2; | |
THPO; LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Enzyme_unclassified | MTOR | Serine/threonine-protein kinase mTOR | P42345 | CHEMBL2842 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Oxidoreductase | PTGS1 | Cyclooxygenase-1 | P23219 | CHEMBL221 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Transient receptor potential channel | TRPA1 | Transient receptor potential cation channel subfamily A member 1 | O75762 | CHEMBL6007 |
Unclassified | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 3.660E-09 | 1.594E-05 | CYP1A2, CYP2C19, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 5.492E-07 | 1.613E-03 | CYP1A2, CYP2C19, CYP2D6, PTGS1 |
MF | GO:0005488; binding | GO:0020037; heme binding | 8.739E-07 | 2.114E-03 | CYP1A2, CYP2C19, CYP2D6, PTGS1 |
MF | GO:0003824; catalytic activity | GO:0016705; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.878E-06 | 3.717E-03 | CYP1A2, CYP2C19, CYP2D6, PTGS1 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 2.131E-06 | 3.867E-03 | ALOX15, CYP1A2, CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 2.561E-06 | 4.291E-03 | CYP1A2, CYP2C19, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0009820; alkaloid metabolic process | 7.417E-06 | 1.009E-02 | CYP1A2, CYP2D6 |
BP | GO:0050896; response to stimulus | GO:0042060; wound healing | 1.306E-05 | 1.673E-02 | ALOX15, MTOR, TP53 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.588E-05 | 1.921E-02 | CYP1A2, CYP2C19 |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 2.327E-05 | 2.303E-02 | SMN1, SMN2 |
MF | GO:0003824; catalytic activity | GO:0004497; monooxygenase activity | 2.455E-05 | 2.324E-02 | CYP1A2, CYP2C19, CYP2D6 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 2.749E-05 | 2.494E-02 | SMN1, SMN2 |
CC | GO:0044464; cell part | GO:0034719; SMN-Sm protein complex | 5.383E-05 | 3.781E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 4.456E-07 | 2.062E-05 | CYP2D6, ALOX15, CYP2C19, PTGS1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 5.977E-07 | 2.062E-05 | CYP1A2, ALOX15, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 6.118E-06 | 1.407E-04 | ALOX15, CYP2C19, PTGS1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 8.456E-06 | 1.459E-04 | CYP2D6, CYP1A2, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05214 | Glioma | 6.722E-04 | 8.211E-03 | TP53, MTOR |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 7.140E-04 | 8.211E-03 | TP53, MTOR |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 1.255E-03 | 9.625E-03 | TP53, MTOR |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 8.470E-04 | 8.349E-03 | CYP2D6, CYP1A2 |
09150 Organismal Systems | 09149 Aging | hsa04211 | Longevity regulating pathway - mammal | 1.399E-03 | 9.653E-03 | TP53, MTOR |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.067E-03 | 9.204E-03 | CYP1A2, CYP2C19 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |